Richard Ofori‐Asenso

61.7k total citations · 2 hit papers
101 papers, 3.5k citations indexed

About

Richard Ofori‐Asenso is a scholar working on Economics and Econometrics, Surgery and Geriatrics and Gerontology. According to data from OpenAlex, Richard Ofori‐Asenso has authored 101 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Economics and Econometrics, 23 papers in Surgery and 20 papers in Geriatrics and Gerontology. Recurrent topics in Richard Ofori‐Asenso's work include Health Systems, Economic Evaluations, Quality of Life (25 papers), Lipoproteins and Cardiovascular Health (14 papers) and Pharmaceutical Practices and Patient Outcomes (14 papers). Richard Ofori‐Asenso is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (25 papers), Lipoproteins and Cardiovascular Health (14 papers) and Pharmaceutical Practices and Patient Outcomes (14 papers). Richard Ofori‐Asenso collaborates with scholars based in Australia, United Kingdom and Denmark. Richard Ofori‐Asenso's co-authors include Akosua Adom Agyeman, Danny Liew, Ken Lee Chin, Ella Zomer, Allyson M Pollock, Sophia Zoungas, Mohsen Mazidi, Andrea J. Curtis, Zanfina Ademi and Cornelia B. Landersdorfer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of the American College of Cardiology.

In The Last Decade

Richard Ofori‐Asenso

94 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Incidence of Frailty and Prefrailty Among Community-Dwelling Older Adults

2019 372 citations Richard Ofori‐Asenso, Ken Lee Chin et al. JAMA Network Open profile →
Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis

2020 303 citations Akosua Adom Agyeman, Ken Lee Chin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard Ofori‐Asenso Australia	31	716	703	641	475	464	101	3.5k
Colin McCowan United Kingdom	36	782 1.1×	626 0.9×	636 1.0×	832 1.8×	268 0.6×	135	4.2k
Bhautesh Jani United Kingdom	31	967 1.4×	917 1.3×	696 1.1×	316 0.7×	676 1.5×	106	3.8k
Brian C. Sauer United States	31	599 0.8×	381 0.5×	398 0.6×	405 0.9×	208 0.4×	177	3.8k
Shaun Wen Huey Lee Malaysia	35	546 0.8×	711 1.0×	374 0.6×	526 1.1×	415 0.9×	209	4.3k
Todd Ruppar United States	29	413 0.6×	987 1.4×	550 0.9×	360 0.8×	294 0.6×	80	4.5k
Giampiero Mazzaglia Italy	37	736 1.0×	536 0.8×	611 1.0×	272 0.6×	254 0.5×	148	4.5k
Bernard Vrijens Belgium	35	437 0.6×	930 1.3×	793 1.2×	334 0.7×	313 0.7×	94	6.0k
Colin R Simpson United Kingdom	40	1.0k 1.4×	334 0.5×	504 0.8×	361 0.8×	971 2.1×	185	5.1k
Przemysław Kardas Poland	27	552 0.8×	1.1k 1.6×	775 1.2×	246 0.5×	250 0.5×	101	4.4k
Kay Stewart Australia	35	438 0.6×	1.4k 2.0×	663 1.0×	933 2.0×	662 1.4×	128	4.0k

Countries citing papers authored by Richard Ofori‐Asenso

Since Specialization

Citations

This map shows the geographic impact of Richard Ofori‐Asenso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Ofori‐Asenso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Ofori‐Asenso more than expected).

Fields of papers citing papers by Richard Ofori‐Asenso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Ofori‐Asenso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Ofori‐Asenso. The network helps show where Richard Ofori‐Asenso may publish in the future.

Co-authorship network of co-authors of Richard Ofori‐Asenso

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Ofori‐Asenso. A scholar is included among the top collaborators of Richard Ofori‐Asenso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Ofori‐Asenso. Richard Ofori‐Asenso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pecoits‐Filho, Roberto, Eiichiro Kanda, Naoki Kashihara, et al.. (2025). Characteristics and cardio-renal outcomes in patients with CKD receiving guideline-directed medical therapy: insights from DISCOVER CKD. Nephrology Dialysis Transplantation. 41(3). 500–510.

Chowdary, Pratima, Richard Ofori‐Asenso, Francis Nissen, et al.. (2024). Disease Burden, Clinical Outcomes, and Quality of Life in People with Hemophilia A without Inhibitors in Europe: Analyses from CHESS II/CHESS PAEDs. SHILAP Revista de lepidopterología. 8(2). e181–e193.

Alikhan, Raza, May Nour, Masahiro Yasaka, et al.. (2024). Design and rationale for REVERXaL: A real-world study of patients with factor Xa inhibitor–associated major bleeds. Thrombosis Research. 240. 109046–109046. 1 indexed citations

Pollock, Carol A., Juan Jesús Carrero, Eiichiro Kanda, et al.. (2024). The Lived Experience of Patients With Chronic Kidney Disease: Insights From DISCOVER CKD. American Journal of Nephrology. 55(6). 618–628.

Naser, Abdallah Y., et al.. (2022). Real World Adherence to and Persistence With Oral Oncolytics in Multiple Myeloma: A Systematic Review and Meta-analysis. Clinical Lymphoma Myeloma & Leukemia. 22(10). 760–773. 4 indexed citations

Morrow, Richard L., Barbara Mintzes, Patrick C. Souverein, et al.. (2022). Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. BMJ Quality & Safety. 31(3). 179–190. 3 indexed citations

Marquina, Clara, Ella Zomer, Sophia Zoungas, et al.. (2020). Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness. PharmacoEconomics. 38(10). 1095–1113. 31 indexed citations

Laar, Amos, et al.. (2020). Rationing health and social goods during pandemics: Guidance for Ghanaian decision makers. Clinical Ethics. 16(3). 165–170. 2 indexed citations

Katsiki, Niki, Richard Ofori‐Asenso, Ele Ferrannini, & Mohsen Mazidi. (2020). Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 22(6). 1001–1005. 5 indexed citations

10.

Smith, Vinayak, Ritesh Rikain Warty, Mohamed Salih, et al.. (2020). Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review. PLoS ONE. 15(6). e0234187–e0234187. 182 indexed citations

11.

Ofori‐Asenso, Richard, Akosua Adom Agyeman, Ken Lee Chin, et al.. (2020). Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysis. ecancermedicalscience. 14. 1047–1047. 26 indexed citations

12.

Kazemi, Asma, et al.. (2020). Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta‐analysis of randomized clinical trials. Phytotherapy Research. 34(7). 1587–1598. 51 indexed citations

13.

Chin, Ken Lee, et al.. (2020). Early signs that COVID-19 is being contained in Australia. Journal of Infection. 81(2). 318–356. 10 indexed citations

14.

Chin, Ken Lee, Richard Ofori‐Asenso, Si Si, et al.. (2019). Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes. Scientific Reports. 9(1). 3256–3256. 16 indexed citations

15.

Ong, Jason J., Teodora Wi, Joseph D. Tucker, et al.. (2019). Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection. JAMA Network Open. 2(12). e1917134–e1917134. 99 indexed citations

16.

Ofori‐Asenso, Richard, Ken Lee Chin, Andrea J. Curtis, et al.. (2018). Recent Patterns of Multimorbidity Among Older Adults in High-Income Countries. Population Health Management. 22(2). 127–137. 129 indexed citations

17.

Ofori‐Asenso, Richard, Jenni Ilomäki, Mark Tacey, et al.. (2018). Prevalence and Incidence of Statin Use and 3-Year Adherence and Discontinuation Rates Among Older Adults With Dementia. American Journal of Alzheimer s Disease & Other Dementias®. 33(8). 527–534. 15 indexed citations

18.

Ofori‐Asenso, Richard, Ella Zomer, Andrea J. Curtis, et al.. (2017). Patterns and Predictors of Adherence to Statin Therapy Among Older Patients: Protocol for a Systematic Review. JMIR Research Protocols. 6(3). e39–e39. 3 indexed citations

19.

Agyeman, Akosua Adom & Richard Ofori‐Asenso. (2017). Tuberculosis—an overview. Journal of Public Health and Emergency. 1. 7–7. 19 indexed citations

20.

Agyeman, Akosua Adom & Richard Ofori‐Asenso. (2014). Linezolid For The Treatment Of Multi-Drug And Extensively Drug Resistant Tuberculosis: A Systematic Review On Efficacy And Toxicity. 13(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact